Biotech mogul Soon-Shiong pumps fortune into cancer fight

Dr. Patrick Soon-Shiong has taken part of his fortune made in the biotech game--via multibillion-dollar sales of his companies Abraxis and APP Pharmaceuticals--and spent it on a high-speed rail of sorts to transport genomic data among researchers and medical care facilities around the U.S. Soon-Shiong's recently launched nonprofit, Chan Soon-Shiong Institute for Advanced Health (CSS Institute), is getting millions of dollars from its founders to support an IT infrastructure that could help speed the translation of scientific discoveries into new treatments for cancer and other diseases. Report

Suggested Articles

Two weeks after receiving a second dose of Moderna's COVID-19 jab, patients had "robust" levels of neutralizing antibodies against the…

Despite questions about eye-related side effects, GlaxoSmithKline's anti-BCMA treatment emerged from an advisory committee meeting with a 12-0 vote.

After Mallinckrodt's terlipressin beat placebo at reversing kidney failure, an FDA panel will discuss the phase 3 trial's surrogate endpoint.